An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1
Samira Jeimy(McMaster University), Catherine P.M. Hayward(Hamilton Regional Laboratory Medicine Program), Elizabeth F. Krakow(Fred Hutch Cancer Center), Subia Tasneem(McMaster University), Nola Fuller(McMaster University)
Cited by 14
Related Papers
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies
|American Journal of Hematology|2004|194
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2017|87
Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients
|Biology of Blood and Marrow Transplantation|2018|49
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia
|JAMA Oncology|2017|48
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning
|American Journal of Epidemiology|2017|42